» Articles » PMID: 9469507

Crescentic Glomerulonephritis Accompanied by Myeloperoxidase-antineutrophil Cytoplasmic Antibodies in a Patient Having Myelodysplastic Syndrome with Trisomy 7

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 1998 Feb 20
PMID 9469507
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

A 63-year-old woman developed rapidly progressive glomerulonephritis syndrome with serum myeloperoxidase-anti-neutrophil cytoplasmic antibodies (MPO-ANCA). A renal biopsy showed diffuse crescentic glomerulonephritis. Immunofluorescence and electron microscopic studies showed no significant deposits in the glomeruli. The morphological findings were consistent with pauci-immune type crescentic glomerulonephritis. In addition, the patient had erythropoietin-resistant anemia and subsequent pancytopenia. Bone marrow was normocellular without an excess of blasts. However, multinuclear erythroblasts, hypersegmented neutrophils, and megakaryocytes without platelet formation were observed. Chromosome analysis of the bone marrow showed 47,XX,+7. This is the first case of MPO-ANCA-related crescentic glomerulonephritis in a patient with myelodysplastic syndromes (MDS). A possible relationship between MPO-ANCA and MDS is discussed.

Citing Articles

Kidney involvement in myelodysplastic syndromes.

Lafargue M, Duong van Huyen J, Rennke H, Essig M, Bobot M, Jourde-Chiche N Clin Kidney J. 2024; 17(8):sfae185.

PMID: 39099564 PMC: 11292217. DOI: 10.1093/ckj/sfae185.


Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes.

Schwotzer N, Provot F, Ville S, Daniel L, Le Fur A, Kissling S Kidney Int Rep. 2021; 6(3):746-754.

PMID: 33732989 PMC: 7938072. DOI: 10.1016/j.ekir.2020.12.030.


[Extramembranous glomerulonephritis and myelodysplastic syndrome: a rare association].

El Mehdi M, Alayoude A, Hamzi M, Arache W, Hassani K, Jennane S Pan Afr Med J. 2018; 29:85.

PMID: 29875966 PMC: 5987118. DOI: 10.11604/pamj.2018.29.85.3486.


Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.

Diamantopoulos P, Michael M, Benopoulou O, Bazanis E, Tzeletas G, Meletis J Virol J. 2012; 9:1.

PMID: 22214262 PMC: 3305386. DOI: 10.1186/1743-422X-9-1.


Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis.

Lien Y, Lai L Nat Rev Nephrol. 2010; 7(2):85-95.

PMID: 21151207 PMC: 3058941. DOI: 10.1038/nrneph.2010.171.